Is hysteroscopic sterilization permanent for women?
Scientists say brain scans show that education appears to lessen the effects of Alzheimer’s disease. The scientists from the Washington University School of Medicine, St. Louis, say their research supports the ‘cognitive reserve’ hypothesis and individuals with levels of higher education levels score higher on cognitive tests despite having Alzheimer’s disease. According to the hypothesis,
Full Post: Education lessens the effects of Alzheimer’s
Women who have decided that they do not want to ever become pregnant often select permanent sterilization.
Patients who opt for hysteroscopic sterilization need to understand that this noninvasive procedure, which offers rapid recovery and return to daily activities, also consists of 2 parts: placement of the device and the confirmatory hysterosalpingogram (HSG). Both parts of the procedure must be performed to ensure that the patient is not at risk for pregnancy. In a recent supplement to OBG Management, Hysteroscopic sterilization: What you need to know about HSG confirmation, Dr Abimbola O. Famuyide, chair, division of gynecology at Mayo Clinic, and Dr John C. Lipman, director of the Interventional Radiologist Center for Image-Guided Procedures at Emory-Adventist Hospital in Atlanta, discuss the importance of collaboration between their specialties to ensure women receive a follow-up HSG after Essure placement.
OBG Management — the number 1 “A-sized” ObGyn specialty journal according to June 2008 FOCUS and MediaChek reports — published Hysteroscopic sterilization: What you need to know about HSG confirmation with a grant from Conceptus, Inc. It is available in print and can be found online at: http://www.obgmanagement.com/pages.asp?id=6824.
OBG Management is published by Dowden Health Media, a Division of Lebhar-Friedman, Inc. Dowden Health Media is a full-service healthcare communications company that specializes in high-quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine and obstetrics/gynecology.
Smith & Nephew’s Endoscopy Division has announced the launch of the CROSSTRAC Hip Guide System, which enables surgeons to accurately establish pathways to diagnose and repair the hip joint using arthroscopy, or minimally invasive, repair procedures. The announcement came at the Arthroscopy Association of North America Fall Course, which opened today and runs through Saturday in
Full Post: New system helps the repair of hip joint using arthroscopy
Researchers S. Stanley Young, Ph.D., Assistant Director of the National Institute of Statistical Sciences, Heejung Bang, Ph.D., of Cornell University and Kutluk Oktay. MD, FACOG, Professor of Obstetrics & Gynecology and Director, Division of Reproductive Medicine & Infertility Department of Obstetrics & Gynecology from New York Medical College, wrote a paper, “Cereal-Induced Gender Selection? Most
Full Post: You may not be what your mother eats
Siemens Healthcare announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer. This non-invasive blood test can be used to help monitor the widely-used Herceptin(R) therapy. Metastatic cancer is an advanced stage
Full Post: Study suggests Siemens non-invasive blood test may have a role in monitoring breast cancer patients’ response to Herceptin
The number of children being adopted from care in Northern Ireland has increased, according to a study by Queen’s University. However, Health Boards and Trusts vary dramatically in their decisions on long-term placements for children in care. From Care to Where? A Care Pathways and Outcomes Report for Practitioners explores the placements of the 374
Full Post: Increase in adoption of children in care in Northern Ireland
The Physicians’ Health Study II is a large-scale, long-term, randomized clinical trial that included 14,641 physicians who were at least 50 years old at enrollment. These physicians were given 400 IU of vitamin E every other day or its placebo, or 500 mg of vitamin C daily or its placebo. Researchers followed these patients for
Full Post: No evidence supporting the use of vitamin E and C in the prevention of cancer